Platelets and platelet extracellular vesicles in drug delivery therapy: A review of the current status and future prospects
Platelets are blood cells that are primarily produced by the shedding of megakaryocytes in the bone marrow. Platelets participate in a variety of physiological and pathological processes in vivo, including hemostasis, thrombosis, immune-inflammation, tumor progression, and metastasis. Platelets have...
Main Authors: | Zhanqiu Dai, Tingxiao Zhao, Nan Song, Kaifeng Pan, Yang Yang, Xunbin Zhu, Pengfei Chen, Jun Zhang, Chen Xia |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1026386/full |
Similar Items
-
Platelet-derived extracellular vesicles ameliorate intervertebral disc degeneration by alleviating mitochondrial dysfunction
by: Zhanqiu Dai, et al.
Published: (2023-02-01) -
Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization
by: Yu-Wen Wu, et al.
Published: (2023-12-01) -
Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
by: Yu-Wen Wu, et al.
Published: (2020-03-01) -
Reshaping the Inflammatory Environment in Rheumatoid Arthritis Joints by Targeting Delivery of Berberine with Platelet‐Derived Extracellular Vesicles
by: Qingle Ma, et al.
Published: (2021-11-01) -
The Impact of Platelet Isolation Protocol on the Release of Extracellular Vesicles
by: Marta Zarà, et al.
Published: (2022-05-01)